Lumretuzumab
Drug Detail
Contact
Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Lumretuzumab |
| Trade Name | |
| Synonyms | RG7116|RO5479599 |
| Drug Descriptions |
Lumretuzumab (RO5479599) is a humanized anti-Her3 (ERBB3) antibody that binds to and inhibits human epidermal growth factor receptor signaling, leading to growth inhibition in tumors (PMID: 26463709, PMID: 31423336). |
| DrugClasses | HER3 (ERBB3) Antibody 28 |
| CAS Registry Number | 1448327-63-6 |
| NCIT ID | C104058 |
Filtering
- Case insensitive filtering will display rows if any text in any cell matches the filter term
- Use simple literal full or partial string matches
- Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
- Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
- Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")
Sorting
- Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
- Click on any column header arrows to sort by that column
- Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Carboplatin + Lumretuzumab + Paclitaxel | Carboplatin Lumretuzumab Paclitaxel | 0 | 0 |
| Cetuximab + Lumretuzumab | Cetuximab Lumretuzumab | 0 | 0 |
| Erlotinib + Lumretuzumab | Erlotinib Lumretuzumab | 0 | 0 |
| Lumretuzumab | Lumretuzumab | 0 | 0 |
| Lumretuzumab + Paclitaxel | Lumretuzumab Paclitaxel | 0 | 0 |
| Lumretuzumab + Pertuzumab | Lumretuzumab Pertuzumab | 0 | 0 |
CKB BOOST